Harrison.ai Welcomes Four New AI Partners to Its Open Platform Ecosystem

After launching its Open Platform last year, Harrison.ai has added four additional artificial intelligence (AI) companies to the program. The new entrants are AIRAmed, Koios Medical, Lunit and Nanox AI.

“Through our collaboration with Harrison.ai, we are expanding Nanox’s commercial footprint by bringing AI solutions with demonstrated real‑world value to healthcare providers at scale, supported by Harrison.ai’s deployment across more than 1,000 healthcare sites worldwide,” Nanox Acting Chairman/CEO Erez Meltzer said.

This expansion reflects the platform’s ongoing mission to give healthcare organizations flexible access to high-quality AI solutions that meet their clinical and operational needs without traditional marketplace mark-ups and fees, according to the company.

“We are delighted to establish this partnership with Harrison.ai, which reflects our shared ambition to advance the adoption of AI in healthcare,” Lunit CEO Brandon Suh stated. “The Harrison Open Platform offers an exceptional foundation for Lunit’s solutions to be surfaced to customers in key markets, and we look forward to collaborating closely—including on joint enterprise opportunities—as we continue to expand our global presence.”

The Open Platform was created to provide greater choice and transparency in medical imaging AI adoption. With these new partners, the platform now offers a wide spectrum of AI solutions for X-rays, CTs, MRIs, mammography, and ultrasound, in addition to Harrison.ai’s native solutions.

“Open ecosystems are essential for the scalable and responsible adoption of medical AI. Healthcare providers should have the flexibility to select best-in-class solutions without commercial barriers or mark-ups,” AIRAmed CEO, neurologist and neuroradiologist Dr. Tobias Lindig commented. “With the emergence of disease-modifying Alzheimer’s therapies, quantitative MR volumetry of the brain is becoming an increasingly important component of patient stratification and treatment planning. Early detection and reliable differential diagnosis are critical, as subtle neurodegenerative changes are often not visible through visual assessment alone. Through our partnership with Harrison.ai, we are expanding access to objective, reproducible brain imaging biomarkers that integrate seamlessly into clinical workflows and support informed, data-driven treatment decisions.”

Each partner brings expertise across different imaging domains, helping healthcare organizations evaluate AI tools that align with their specific workflows, priorities, and patient populations.

“On behalf of Team Koios, we could not be happier to be working closely and aligned with our friends and colleagues at Harrison AI,” Koios Medical President/CEO Chad McClennan said. “Having known and watched Dr. Aengus and Dimitry Tran since the early years, there is no doubt we are like-minded in terms of our commitment to patient care, provider access to proven solutions and delivering excellent patient and customer experiences.”

The Open Platform operates on an open architecture model with a customer ROI-first approach and zero mark-ups to the vendors. Harrison.ai provides the infrastructure that enables healthcare providers to build an AI ecosystem tailored to their needs, with clarity around pricing and value. The platform does not block competing applications that meet industry-standard containerization specifications, even those that compete directly with Harrison.ai’s own solutions. Healthcare organizations integrate once through vendor-neutral interfaces to their PACS, RIS, and EHR systems, then have the option to access a full catalog of AI applications.

As global adoption of medical imaging AI continues to grow, the Harrison.ai Open Platform is designed to evolve alongside customer requirements, supporting collaboration across the ecosystem and helping healthcare organisations select the algorithms that best fit their needs.

Harrison.ai is a global healthcare technology company that enhances clinician capacity and patient care through AI automation. Clinician-led and patient-first, our suite of solutions supports earlier, more accurate diagnoses and seamlessly integrates into clinical workflows. Harrison.ai solutions are available in more than 40 countries and to half of all Australian radiologists. They are clinically deployed at over 1,000 customer sites globally, including 40-plus NHS Trusts and all public emergency departments in Hong Kong. With more than 3,400 clinicians using its tools, Harrison.ai has impacted over 7 million patients’ lives to date.